Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study

医学 垂体机能减退 蛛网膜下腔出血 前瞻性队列研究 改良兰金量表 内科学 队列 格拉斯哥结局量表 儿科 格拉斯哥昏迷指数 麻醉 缺血性中风 缺血
作者
Chiara Robba,Raffaele Aspide,Marianna Pegoli,Ekaterina A. Kondratyeva,Paolo Gritti,Marco Faustini Fustini,Denise Battaglini,Paolo Pelosi,Peter J. Hutchinson,Adel Helmy,Carlo Bortolotti,Corrado Zenesini,Federico Bilotta
出处
期刊:Journal of Neurosurgical Anesthesiology [Lippincott Williams & Wilkins]
卷期号:34 (1): 44-50 被引量:6
标识
DOI:10.1097/ana.0000000000000705
摘要

Background: The prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage (aSAH) remains incompletely elucidated. Furthermore, it is not clear whether these abnormalities impact patient outcomes. The aim of this study was to evaluate the prevalence of pituitary dysfunction after aSAH and its effect on outcomes. Methods: We carried out a prospective, cohort study including adult patients (18 y of age or older) with a diagnosis of aSAH who were admitted to the intensive care unit in 3 centers between January 2017 and January 2019. Exclusion criteria were previous hypopituitarism, hormonal replacement therapies for pituitary dysfunction or any corticosteroid treatment. Endocrine function was tested within the first 48 hours after aSAH onset (acute phase), after 1 to 3 weeks (subacute phase), and after 6 to 12 months (chronic phase). Clinical outcomes were assessed at 6 to 12 months using the modified Rankin Scale. Results: Fifty-six patients were included in the study; all were studied in the acute phase, 34 were studied in the subacute phase, and 49 in the chronic phase. Pituitary dysfunction was identified in 92.3% (95% confidence interval; [CI]: 86.6%-98.0%) of cases in the acute phase, in 83.3% (95% CI: 70.8%-95.8%) in the subacute phase, and in 83.3% (95% CI: 72.7%-93.9%) of cases in the chronic phase. The most commonly identified abnormality was dysfunction of the pituitary-gonadal axis. There was no correlation between pituitary dysfunction and clinical outcome. Conclusion: Pituitary dysfunction is common after aSAH, but does not affect 6 to 12-month clinical outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
月昔完成签到 ,获得积分10
2秒前
2秒前
小胖子完成签到 ,获得积分10
3秒前
lili完成签到 ,获得积分20
6秒前
甜美阁完成签到,获得积分10
10秒前
10秒前
Aiden完成签到,获得积分10
11秒前
缥缈雯完成签到,获得积分10
13秒前
17秒前
bohe完成签到 ,获得积分10
20秒前
呼延香之发布了新的文献求助20
22秒前
24秒前
Aoiny完成签到,获得积分10
24秒前
秋99完成签到 ,获得积分10
27秒前
墨林云海完成签到,获得积分10
28秒前
孙一完成签到 ,获得积分0
29秒前
31秒前
大个的应助被澄黄澄采纳,获得10
31秒前
小王找文献完成签到 ,获得积分10
31秒前
31秒前
芝诺的乌龟完成签到 ,获得积分0
34秒前
夕阳完成签到 ,获得积分10
34秒前
37秒前
seujyc完成签到 ,获得积分10
39秒前
小范完成签到 ,获得积分10
40秒前
40秒前
老迟到的寻绿完成签到 ,获得积分10
41秒前
lwroche完成签到,获得积分10
41秒前
中恐完成签到,获得积分0
43秒前
44秒前
澄黄澄发布了新的文献求助10
45秒前
Akim的应助被呼延香之采纳,获得20
46秒前
清水完成签到 ,获得积分10
47秒前
科研孙一完成签到,获得积分10
49秒前
Centaurodendron完成签到,获得积分10
49秒前
WXF完成签到 ,获得积分10
49秒前
52秒前
53秒前
空勒完成签到,获得积分10
55秒前
勤劳的政桦完成签到,获得积分10
57秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190366
求助须知:如何正确求助?哪些是违规求助? 9577437
关于积分的说明 21852521
捐赠科研通 7788988
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560144
邀请新用户注册赠送积分活动 2482995